The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats

Thrombosis Research

Volumn 131, Issue 1, 2013, Pages 59-63

  Morishima, Yoshiyuki ^a   Kamisato, Chikako ^a   Honda, Yuko ^a   Furugohri, Taketoshi ^a   Shibano, Toshiro ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Carboxylation; Edoxaban; Osteocalcin; Osteoporosis; Warfarin

Indexed keywords

EDOXABAN; HYDROXYAPATITE; OSTEOCALCIN; WARFARIN;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; CARBOXYLATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; CARBOXYLIC ACIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XA; MALE; OSTEOCALCIN; OSTEOPOROSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTHROMBIN TIME; PYRIDINES; RATS; RATS, WISTAR; RISK FACTORS; THIAZOLES; TIME FACTORS; VITAMIN K; WARFARIN;

EID: 84871663527     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.08.304     Document Type: Article

References (24)

1. K. Kruse, and U. Kracht Evaluation of serum osteocalcin as an index of altered bone metabolism Eur J Pediatr 145 1986 27 33 (Pubitemid 16097662)
2. D.M. Slovik, C.M. Gundberg, R.M. Neer, and J.B. Lian Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting J Clin Endocrinol Metab 59 1984 228 230 (Pubitemid 14053645)
3. P. Vergnaud, P. Garnero, P.J. Meunier, G. Bréart, K. Kamihagi, and P.D. Delmas Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study J Clin Endocrinol Metab 82 1997 719 724 (Pubitemid 27106576)
4. L.J. Sokoll, M.E. O'Brien, M.E. Camilo, and J.A. Sadowski Undercarboxylated osteocalcin and development of a method to determine vitamin K status Clin Chem 41 1995 1121 1128
5. R.K. Menon, D.S. Gill, M. Thomas, P.B. Kernoff, and P. Dandona Impaired carboxylation of osteocalcin in warfarin-treated patients J Clin Endocrinol Metab 64 1987 59 61 (Pubitemid 17015878)
6. W.J. Philip, J.C. Martin, J.M. Richardson, D.M. Reid, J. Webster, and A.S. Douglas Decreased axial and peripheral bone density in patients taking long-term warfarin Q J Med 88 1995 635 640
7. P.J. Caraballo, J.A. Heit, E.J. Atkinson, M.D. Silverstein, W.M. O'Fallon, and M.R. Castro Long-term use of oral anticoagulants and the risk of fracture Arch Intern Med 59 1999 1750 1756 (Pubitemid 29379138)
8. B.F. Gage, E. Birman-Deych, M.J. Radford, D.S. Nilasena, and E.F. Binder Risk of osteoporotic fracture in elderly patients taking warfarin. Results from the National Registry of Atrial Fibrillation 2 Arch Intern Med 166 2006 241 246 (Pubitemid 43144951)
9. J.M. Pettifor, and R. Benson Congenital malformations associated with the administration of oral anticoagulants during pregnancy J Pediatr 86 1975 459 462
10. R.M. Pauli, J.B. Lian, D.F. Mosher, and J.W. Suttie Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives Am J Hum Genet 41 1987 566 583 (Pubitemid 18031530)
11. T. Furugohri, K. Isobe, Y. Honda, C. Kamisato-Matsumoto, N. Sugiyama, and T. Nagahara Shibano T.DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles J Thromb Haemost 6 2008 1542 1549
12. S. Fujita, T. Fuji, S. Tachibana, M. Nakamura, and M. Kawai Safety and efficacy of edoxaban in patients undergoing hip fracture surgery Pathophysiol Haemost Thromb 37 2010 A95 [P366]
13. T. Fuji, S. Fujita, S. Tachibana, Y. Kawai, Y. Koretsune, and T. Yamashita Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V trial Blood 116 2010 3320 [ASH Annual Meeting Abstracts]
14. T. Fuji, S. Fujita, S. Tachibana, and Y. Kawai A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty J Thromb Haemost 8 2010 2458 2468
15. C.T. Ruff, R.P. Giugliano, E.M. Antman, S.E. Crugnale, T. Bocanegra, and M. Mercuri Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48) Am Heart J 160 2010 635 641
16. K. Ogata, J. Mendell-Harary, M. Tachibana, H. Masumoto, T. Oguma, and M. Kojima Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers J Clin Pharmacol 50 2010 743 753
17. T. Sugiyama, T. Takaki, K. Sakanaka, H. Sadamaru, K. Mori, and Y. Kato Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli J Endocrinol 194 2007 213 222 (Pubitemid 47162900)
18. P. Broulík, and M. Hrubý Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure Cas Lek Cesk 132 1993 681 683
19. S.A. Jamal, W.S. Browner, D.C. Bauer, and S.R. Cummings Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group Ann Intern Med 128 1998 829 832 (Pubitemid 28267716)
20. D. Pilon, A.M. Castilloux, M. Dorais, and J. LeLorier Oral anticoagulants and the risk of osteoporotic fractures among elderly Pharmacoepidemiol Drug Saf 13 2004 289 294 (Pubitemid 38697049)
21. D.A. Pearson Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants Nutr Clin Pract 22 2007 517 544
22. G. Matziolis, C. Perka, A. Disch, and H. Zippel Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts Calcif Tissue Int 73 2003 370 379 (Pubitemid 37409424)
23. A.E. Handschin, O.A. Trentz, S.P. Hoerstrup, H.J. Kock, G.A. Wanner, and O. Trentz Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro Br J Surg 92 2005 177 183 (Pubitemid 40269331)
24. G.N. Solayar, P.M. Walsh, and K.J. Mulhall The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin BMC Musculoskelet Disord 12 2011 247 254